Mark Levis, MD, PhD, is Professor of Oncology and Program Leader for the Hematologic Malignancies and Bone Marrow Transplant Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine.
Dr Levis’ research focuses on the development of molecularly targeted therapies for leukemia, particularly those targeting the FLT3 signaling pathway. He is actively involved in the pre-clinical development of these therapies, and is particularly interested in translating this research into clinical practice.
Dr Levis has earned numerous awards, including the ASCO Advanced Clinical Research Award, and has conducted many talks, mentorship and teaching lectures. He has also contributed extensively to numerous papers published in the top journals in his field, including Leukemia, Blood and the New England Journal of Medicine.